본문 바로가기
KERD
논문KCI 등재

Korean Guideline for the Diagnosis and Treatment of Onychomycosis: Purpose and Process of Algorithm Guideline Development

김효진|이지현|이원주|최종수|김광호|박준수|이양원|이지범|고현창|문제호|서무규|박진|남재희
대한의진균학회 (The Korean Society for Medical Mycology)|2018.06|대한의진균학회지 (Journal of Mycology and Infection)|제23권 제2호|pp. 33-44|DOI 10.17966/jmi.2018.23.2.33

2

조회

0

다운로드

7

인용

0

참고문헌

키워드

GuidelineTreatmentDiagnosisOnychomycosis
주제분류미생물학

초록

Background: There have been several therapeutic guidelines for onychomycosis in different countries and advances in its diagnosis and treatment. Optimal treatment decision-making is affected by healthcare systems and cultural backgrounds of countries. Objective: The executive committee for onychomycosis guideline of the Korean Society for Medical Mycology aims to provide up-to-date practical guidelines for onychomycosis management in Koreans. Methods: The committee thoroughly reviewed relevant literature and previous guidelines. The structured algorithmic guideline was developed by experts' consensus. Results: The optimal treatments can be selected alone or in combination based on the nail and patient variables. Three major classes of treatment are available: standard (topical or oral antifungals), additional (nail removal), and alternative treatments (laser). Both topical and oral antifungals alone are appropriate for mild onychomycosis, while oral antifungals are primarily recommended for moderate-to-severe cases if not contraindicated. Combined topical and oral antifungals are recommended to increase the efficacy in moderate-to-severe cases. Additional infected nail removal is also considered for moderate-to-severe onychomycosis, which is unresponsive to standard medical treatment alone. Laser therapy can be an alternative without significant side effects when standard medical treatments cannot be applied regardless of onychomycosis severity. After treatment course completion, periodic therapeutic response monitoring and onychomycosis preventive measures should be rendered to reduce recurrence. Conclusion: The Korean consensus guideline provides evidence-based recommendations to promote good outcomes of onychomycosis. The proposed algorithm is simple and easy to comprehend, allowing clinicians to facilitate optimal treatment decision-making for onychomycosis in clinical practice.

Abstract

Background: There have been several therapeutic guidelines for onychomycosis in different countries and advances in its diagnosis and treatment. Optimal treatment decision-making is affected by healthcare systems and cultural backgrounds of countries. Objective: The executive committee for onychomycosis guideline of the Korean Society for Medical Mycology aims to provide up-to-date practical guidelines for onychomycosis management in Koreans. Methods: The committee thoroughly reviewed relevant literature and previous guidelines. The structured algorithmic guideline was developed by experts' consensus. Results: The optimal treatments can be selected alone or in combination based on the nail and patient variables. Three major classes of treatment are available: standard (topical or oral antifungals), additional (nail removal), and alternative treatments (laser). Both topical and oral antifungals alone are appropriate for mild onychomycosis, while oral antifungals are primarily recommended for moderate-to-severe cases if not contraindicated. Combined topical and oral antifungals are recommended to increase the efficacy in moderate-to-severe cases. Additional infected nail removal is also considered for moderate-to-severe onychomycosis, which is unresponsive to standard medical treatment alone. Laser therapy can be an alternative without significant side effects when standard medical treatments cannot be applied regardless of onychomycosis severity. After treatment course completion, periodic therapeutic response monitoring and onychomycosis preventive measures should be rendered to reduce recurrence. Conclusion: The Korean consensus guideline provides evidence-based recommendations to promote good outcomes of onychomycosis. The proposed algorithm is simple and easy to comprehend, allowing clinicians to facilitate optimal treatment decision-making for onychomycosis in clinical practice.

참고문헌 (55)

  1. Schieke SM, "Fitzpatrick's dermatology in general medicine", pp.2277~2297 (2012), McGraw-Hill
  2. Thomas J, "Toenail onychomycosis: an important global disease burden", J Clin Pharm Ther, 35, pp.497~519 (2010)[DOI]
  3. 주지영, "A Clinical and Mycological Study of Onychomycosis in the Elderly Over 10 Years (2001-2010)", 대한의진균학회지, 19(4), pp.83~92 (2014), 대한의진균학회[DOI]
  4. 황성민, "한국인의 손발톱진균증 환자의 역학적 조사: 다기관 연구", 대한의진균학회지, 16(2), pp.35~43 (2011), 대한의진균학회[DOI]
  5. Drake LY, "Guidelines of care for superficial mycotic infections of the skin: onychomycosis. Guidelines", Outcomes Committee. American Academy of Dermatology, 1996, pp.34, 116~121
  6. Roberts DT, "Guidelines for treatment of onychomycosis", Br J Dermatol, 148, pp.402~410 (2003)[DOI]
  7. Lecha M, "Taskforce on Onychomycosis Education. Treatment options - development of consensus guidelines", J Eur Acad Dermatol Venereol, 19(Suppl. 1), pp.25~33 (2005)[DOI]
  8. Ameen M, "British Association of Dermatologists' guidelines for the management of onychomycosis 2014", Br J Dermatol, 171, pp.937~958 (2014)[DOI]
  9. Gupta AK, "Toenail onychomycosis-A Canadian approach with a new transungual treatment: development of a clinical pathway", J Cutan Med Surg, 19, pp.440~449 (2015)[DOI]
  10. Vlahovic TC, "Diagnosis and management of onychomycosis perspectives from a joint podiatric medicinedermatology roundtable", J Am Podiatr Med Assoc, 106, pp.155~162 (2016)[DOI]
  11. Korean Taskforce on Onychomycosis Education (K-TOE), "Onychomycosis; guidebook for dermatologists at clinic and residents" (2008), Seoheung Co.
  12. Piraccini BM, "Nail digital dermoscopy (onychoscopy) in the diagnosis of onychomycosis", J Eur Acad Dermatol Venereol, 27, pp.509~513 (2013)[DOI]
  13. El-Hoshy KH, "Nail dermoscopy is a helpful tool in the diagnosis of onychomycosis: A case control study", Eur J Dermatol, 25, pp.494~495 (2015)
  14. 박진, "얕은피부진균증의 더모스코피", 대한의진균학회지, 22(2), pp.53~61 (2017), 대한의진균학회[DOI]
  15. 김원정, "손발톱진균증으로 오진 후 항진균제가 투여된 손발톱질환에 대한 임상적 연구", 대한피부과학회지, 49(05), pp.408~414 (2011), 대한피부과학회
  16. Weinberg JM, "Comparison of diagnostic methods in the evaluation of onychomycosis", J Am Acad Dermatol, 49, pp.193~197 (2003)
  17. Velasquez-Agudelo V, "Meta-analysis of the utility of culture, biopsy, and direct KOH examination for the diagnosis of onychomycosis", BMC Infect Dis, 17, pp.166~ (2017)[DOI]
  18. Jung MY, "Comparison of diagnostic methods for onychomycosis, and proposal of a diagnostic algorithm", Clin Exp Dermatol, 40, pp.479~484 (2015)[DOI]
  19. Petinataud D, "Molecular diagnosis of onychomycosis", J Mycol Med, 24, pp.287~295 (2014)[DOI]
  20. 김준군, "손발톱진균증 진단에서 PCR-REBA의 임상적 유용성", 대한의진균학회지, 22(2), pp.62~72 (2017), 대한의진균학회[DOI]
  21. Carney C, "A new classification system for grading the severity of onychomycosis: Onychomycosis severity index", Arch Dermatol, 147, pp.1277~1282 (2011)[DOI]
  22. Sergeev AY, "The Scoring Clinical Index for Onychomycosis (SCIO Index)", Skin Therapy Lett, 7(Suppl. 1), pp.6~7 (2002)
  23. Hay RJ, "Onychomycosis: a proposed revision of the clinical classification", J Am Acad Dermatol, 65, pp.1219~1227 (2011)[DOI]
  24. Rosen T, "Antifungal drugs for onychomycosis: efficacy, safety, and mechanisms of action", Semin Cutan Med Surg, 35, pp.51~55 (2016)[DOI]
  25. 김효진, "손발톱진균증의 전신 항진균제", 대한의진균학회지, 21(4), pp.105~110 (2016), 대한의진균학회[DOI]
  26. de Sa DC, "Oral therapy for onychomycosis: an evidence-based review", Am J Clin Dermatol, 15, pp.17~36 (2014)
  27. Gupta AK, "Cumulative metaanalysis of systemic antifungal agents for the treatment of onychomycosis", Br J Dermatol, 150, pp.537~544 (2004)[DOI]
  28. Gupta AK, "Network meta-analysis of onychomycosis treatments", Skin Appendage Disord, 1, pp.74~81 (2015)[DOI]
  29. Sigurgeirsson B, "L.I.ON. Study: Efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis", Br J Dermatol, 141(Suppl. 56), pp.5~14 (1999)[DOI]
  30. Sigurgeirsson B, "Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study", Arch Dermatol, 138, pp.353~357 (2002)
  31. Lee KH, "Efficacy of oral terbinafine in the treatment of onychomycosis", Korean J Dermatol, 31, pp.567~580 (1993)
  32. Gupta AK, "Itraconazole pulse therapy for the treatment of Candida onychomycosis", J Eur Acad Dermatol Venereol, 15, pp.112~115 (2001)[DOI]
  33. Gupta AK, "Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature", J Cutan Med Surg, 5, pp.206~210 (2001)[DOI]
  34. Kim JA, "Therapeutic efficacy of orally administered itraconazole in onychomycosis", Korean J Dermatol, 30, pp.508~518 (1992)
  35. Scher RK, "Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail", J Am Acad Dermatol, 8, pp.77~86 (1998)
  36. Gupta AK, "Systemic antifungals to treat onychomycosis in children: a systematic review", Pediatr Dermatol, 30, pp.294~302 (2013)[DOI]
  37. Murdan S, "Drug delivery to the nail following topical application", Int J Pharm, 236, pp.1~26 (2002)[DOI]
  38. Gupta AK, "Topical therapy for toenail onychomycosis: an evidence-based review", Am J Clin Dermatol, 15, pp.489~502 (2014)[DOI]
  39. 이지현, "손발톱진균증의 국소치료", 대한의진균학회지, 21(2), pp.27~33 (2016), 대한의진균학회[DOI]
  40. Baran R, "An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis", J Eur Acad Dermatol Venereol, 23, pp.773~781 (2009)[DOI]
  41. Elewski BE, "Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies", J Am Acad Dermatol, 68, pp.600~608 (2013)[DOI]
  42. Feng X, "Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review", Dermatol Ther, 30, pp.e12457~ (2017)[DOI]
  43. Gupta AK, "Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study", J Drugs Dermatol, 4, pp.481~485 (2005)
  44. Gupta AK, "Therapies for the treatment of onychomycosis", Clin Dermatol, 31, pp.544~554 (2013)[DOI]
  45. Grover C, "Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial", Br J Dermatol, 157, pp.364~368 (2007)[DOI]
  46. Tietz HJ, "Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a doubleblind, randomized, placebo-controlled multicenter study", Mycoses, 56, pp.414~421 (2013)[DOI]
  47. Francuzik W, "Laser therapies for onychomycosis - critical evaluation of methods and effeciveness", J Eur Acad Dermatol Venereol, 30, pp.936~942 (2016)[DOI]
  48. Gupta AK, "A critical review of improvement rates for laser therapy used to treat toenail onychomycosis", J Eur Acad Dermatol Venereol, 31, pp.1111~1118 (2017)[DOI]
  49. 남재희, "레이저와 광치료를 이용한 손발톱진균증의 치료", 대한의진균학회지, 22(3), pp.87~97 (2017), 대한의진균학회[DOI]
  50. Sotiriou E, "Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: Preliminary results of a single-centre open trial", Acta Derm Venereol, 90, pp.216~217 (2010)[DOI]
  51. Figueiredo Souza L, "Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis", Dermatol Ther, 27, pp.43~47 (2014)[DOI]
  52. Scher RK, "Onychomycosis: diagnosis and definition of cure", J Am Acad Dermatol, 56, pp.939~944 (2007)[DOI]
  53. 고현창, "손발톱진균증의 치료효과 증가", 대한의진균학회지, 21(3), pp.59~64 (2016), 대한의진균학회[DOI]
  54. Piraccini BM, "Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents", J Am Acad Dermatol, 62, pp.411~414 (2010)[DOI]
  55. Suh MK, "Treatment and prophylaxis of onychomycosis", Korean J Med Mycol, 6, pp.140~142 (2001)

관련 논문AI추천

손발톱진균증의 치료효과 증가고현창, 김우일대한의진균학회 · 대한의진균학회지2016 · 제21권 제3호손발톱진균증의 전신 항진균제김기홍, 김효진, 박소희대한의진균학회 · 대한의진균학회지2016 · 제21권 제4호손발톱진균증의 국소치료이양원, 이지현대한의진균학회 · 대한의진균학회지2016 · 제21권 제2호발톱진균증 환자에서 환자의 임상적 특성 및 치료방법에 따른 KOH 검사 음성전환기간의 비교강명승, 김정수, 백준오, 유희준대한의진균학회 · 대한의진균학회지2013 · 제18권 제1호발톱진균증의 침범 정도에 따른 완치율과 정상화까지의 기간 및 재발률강명승, 김정수, 유희준대한의진균학회 · 대한의진균학회지2008 · 제13권 제2호레이저와 광치료를 이용한 손발톱진균증의 치료김정엽, 남재희대한의진균학회 · 대한의진균학회지2017 · 제22권 제3호

이 간행물의 다른 논문 (4건)

Epidemiology and Identification of Organisms Causing Superficial Dermatomycoses at Tertiary Hospitals in Korea: A Prospective Multicenter Study유희준, 이지범, 고현창, 문제호, 서무규, 천상진, 김효진, 이지현, 최응호, 최종수, 박준수, 이양원, 박진, 이성열pp. 45-53Familial Sporotrichosis Due to Human-to-human Infection of Sporothrix globosa: A Case Repor김준군, 유문형, 최종수, 김혜리, 신동훈pp. 54-58Macroscopic and Microscopic Findings of Cladosporium sphaerospermum박준수, 나누리, 최용우pp. 59-60Macroscopic and Microscopic Findings of Trichophyton tonsurans이동원, 서무규, 하경임, 홍준석pp. 61-62
원문 보기